High Density Lipoprotein Metabolism in Man
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The turnover of (125)I-high density lipoprotein (HDL) was examined in a total of 14 studies in eight normal volunteers in an attempt to determine the metabolic relationship between apolipoproteins A-I (apoA-I) and A-II (apoA-II) of HDL and to define further some of the determinants of HDL metabolism. All subjects were first studied under conditions of an isocaloric balanced diet (40% fat, 40% carbohydrate). Four were then studied with an 80% carbohydrate diet, and two were studied while receiving nicotinic acid (1 g three times daily) and ingesting the same isocaloric balanced diet. The decay of autologous (125)I-HDL and the appearance of urinary radioactivity were followed for at least 2 wk in each study. ApoA-I and apoA-II were isolated by Sephadex G-200 chromatography from serial plasma samples in each study. The specific activities of these peptides were then measured directly. It was found that the decay of specific activity of apoA-I and apoA-II were parallel to one another in all studies. The mean half-life of the terminal portion of decay was 5.8 days during the studies with a balanced diet.Mathematical modeling of the decay of plasma radioactivity and appearance of urinary radioactivity was most consistent with a two-compartment model. One compartment is within the plasma and exchanges with a nonplasma component. Catabolism occurs from both of these compartments. With a balanced isocaloric diet, the mean synthetic rate for HDL protein was 8.51 mg/kg per day. HDL synthesis was not altered by the high carbohydrate diet and was only slightly decreased by nicotinic acid treatment. These perturbations had effects on HDL catabolic pathways that were reciprocal in many respects. With an 80% carbohydrate diet, the rate of catabolism from the plasma compartment rose by a mean of 39.1%; with nicotinic acid treatment, it fell by 42.2%. Changes in the rate of catabolism from the second compartment were generally opposite those in the rate of catabolism from the plasma compartment, suggesting that these two catabolic pathways may be reciprocally regulated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Self-citationWeber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 20,298
Phosphorus Assay in Column Chromatography
Bartlett, G. R. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70226-3 · Cited by 12,801
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,818
Self-citationA molecular theory of lipid—protein interactions in the plasma lipoproteins
Segrest, J. P., Jackson, R. L., Morrisett, J. D., & Gotto, A. M. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80064-5 · Cited by 726
A protein cofactor of lecithin:Cholesterol acyltransferase
Fielding, C. J., Shore, V. G., & Fielding, P. E. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90776-0 · Cited by 724
Cited by
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,210
Self-citationWang, N., Lan, D., Chen, W., Matsuura, F., & Tall, A. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403506101 · Cited by 1,061
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. A. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
Tall, A. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114722 · Cited by 652
Kamanna, V. S., & Kashyap, M. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.029 · Cited by 453
Tall, A. R. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01898.x · Cited by 436
Lipoprotein apoprotein metabolism.
Schaefer, E. J., Eisenberg, S., & Levy, R. I. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41267-2 · Cited by 385
Self-citationGPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing
Benyó, Z., Gille, A., Kero, J., Csiky, M., Suchánková, M. C., Nüsing, R. M., Moers, A., Pfeffer, K., & Offermanns, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23626 · Cited by 340
Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
Gille, A., Bodor, E. T., Ahmed, K., & Offermanns, S. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094746 · Cited by 311
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 304
The effect of diet on plasma lipids, lipoproteins, and coronary heart disease
Kris-Etherton, P. M., Krummel, D., Russell, M. E., Dreon, D., Mackey, S., Borchers, J., & Wood, P. D. (1988) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)08023-8 · Cited by 303
Schwartz, C. C., Halloran, L. G., Vlahcevic, Z. R., Gregory, D. H., & Swell, L. (1978) · Science · doi:10.1126/science.204996 · Cited by 302
Ginsberg, H. N., Kris-Etherton, P., Dennis, B., Elmer, P. J., Ershow, A., Lefevre, M., Pearson, T., Roheim, P., Ramakrishnan, R., Reed, R., et al. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.3.441 · Cited by 294
Intestinal lipoprotein metabolism
Green, P. H., & Glickman, R. M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37308-9 · Cited by 270
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114405 · Cited by 264
Self-citationBrinton, E. A., Eisenberg, S., & Breslow, J. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115028 · Cited by 259
Self-citationRedgrave, T. G., & Small, D. M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109435 · Cited by 237
High-Density Lipoprotein and Coronary Heart Disease
Natarajan, P., Ray, K. K., & Cannon, C. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.008 · Cited by 230
Apolipoprotein E synthesis in human kidney, adrenal gland, and liver
Blue, M. L., Williams, D. L., Zucker, S., Khan, S. A., & Blum, C. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.283 · Cited by 226
Self-citationSchaefer, E. J., Levy, R. I., Ernst, N. D., Van Sant, F. D., & Brewer, H. B. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.9.1758 · Cited by 211
Self-citationHuman apolipoprotein A-I and A-II metabolism
Schaefer, E. J., Zech, L. A., Jenkins, L. L., Bronzert, T. J., Rubalcaba, E. A., Lindgren, F. T., Aamodt, R. L., & Brewer, H. B. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38087-1 · Cited by 207
Jin, F.-Y., Kamanna, V. S., & Kashyap, M. L. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2020 · Cited by 193
Wolinsky, H. (1980) · Circulation Research · doi:10.1161/01.res.47.3.301 · Cited by 181
The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target
OFFERMANNS, S. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.05.008 · Cited by 180
Novel HDL-directed pharmacotherapeutic strategies
deGoma, E. M., & Rader, D. J. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.200 · Cited by 149
“Kinetic studies in humans, on the other hand, demonstrate either decreased clearanc”
BackgroundAlderman, J. D., Pasternak, R. C., Sacks, F. M., Smith, H. S., Monrad, E. S., & Grossman, W. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90754-6 · Cited by 80
Schaefer, E. J., Anderson, D. W., Zech, L. A., Lindgren, F. T., Bronzert, T. B., Rubalcaba, E. A., & Brewer, H. B. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35365-7 · Cited by 74
Gylling, H., Vega, G., & Grundy, S. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41407-5 · Cited by 67
Mulder, M., & Terwel, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022429 · Cited by 40
Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans
Marsh, J. B., Welty, F. K., & Schaefer, E. J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00006 · Cited by 38
Metadata
- Authors
- Blum, C. B., Levy, R. I., Eisenberg, S., Hall, M., Goebel, R. H., & Berman, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1977-10-01
- Volume
- 60
- Issue
- 4
- Pages
- 795-807
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1976744580
- Cited by
- 405
- References
- 43
- FWCI
- 43.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.